← All trials
NCT04756310
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 30, 2014
- Primary completion
- Apr 30, 2018
- Completion date
- Apr 30, 2018
- First posted
- Feb 16, 2021
- Last posted
- Feb 16, 2021
- Enrollment
- 109
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Laboratoires TheaLead sponsor
- University of SalamancaOverall official - principal investigator
- Clinica Universidad de NavarraStudy director
- Alpha Bioresearch S.L.Collaborator
- Instituto de Retina e Diabetes Ocular de LisboaOverall official - principal investigator
- Association for Innovation and Biomedical Research on Light and Image (AIBILI)Study director
- University of SantiagoOverall official - principal investigator
- Vall d'Hebron Institute of Research, Galatea ClinicOverall official - principal investigator
- University of ValenciaOverall official - principal investigator
- Investigación EstadísticaCollaborator
- Sorbonne UniversityOverall official - principal investigator
- Hospital Dos de MaigOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.